<DOC>
	<DOCNO>NCT03040804</DOCNO>
	<brief_summary>To establish safety radiotherapy treatment advance hidradenitis suppurativa . Patients receive radiotherapy treatment one week follow next three month .</brief_summary>
	<brief_title>Low Dose Radiotherapy Advanced Hidradenitis Suppurativa</brief_title>
	<detailed_description>This phase I clinical trial use Simon-two stage design establish safety radiotherapy treatment advance hidradenitis suppurativa ( HS ) . In first six month , 6 patient enrol , patient study meet termination criterion , study extend second stage . A maximum 20 patient enrol . Patients treat skin-directed radiotherapy , use total prescription dose 7.5 Gy five fraction 1.5 Gy one week . Patients see HS specialty clinic Montefiore Medial Center least three month . Quality life change , immunohistochemical change , cutaneous discharge also evaluate study period .</detailed_description>
	<mesh_term>Hidradenitis</mesh_term>
	<mesh_term>Hidradenitis Suppurativa</mesh_term>
	<criteria>Diagnosis HS make Montefiore Hs Treatment Center , Hurley Stage 23 ( define recurrent abscesses boil diffuse broad involvement , multiple interconnected sinus tract whole area ) Failed maximal medical therapy HS ineligible `` standard '' medical therapy surgery Age &gt; 20 year Women childbearing age : must negative pregnancy test within 72 hour prior start study therapy agree adequate method contraception throughout treatment least 4 week study contraception . Pregnant woman Individuals &lt; 20 year old</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>hidradenitis suppurativa</keyword>
	<keyword>HS</keyword>
	<keyword>radiotherapy</keyword>
</DOC>